CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...
Ewing's Sarcoma is an aggressive pediatric cancer, most commonly caused by the improper fusion of the gene EWS with the gene FLI1. Though the cause has long been known, therapeutic targeting of this fusion has to date proven very difficult. ...
Tags: Ewing's Sarcoma, health, gene
Surgeons' best tools for locating tumors inside the body are often their hands. But during minimally invasive surgeries—which can reduce recovery time by days—the ability to examine tissue through touch, called palpation, is ...
Tags: Electrical, Electronics
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell (CTC) and other rare cell capture from biological samples. The IsoFlux Rare Cell ...
What is ETMR/ETANTR and who does it affect? Embryonal tumours with multilayered rosettes (ETMR) are rare, deadly brain tumours that affect mainly children below the age of 4 years. There are 300 cases reported but probably there are many ...
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical's new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin ...
A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly "triple negative" breast cancers (TNBC). These tumors are extremely ...
Tags: Life-Saving Treatments, ight Tumor Metastasis, Life-Saving
Johnson & Johnson has found a private equity firm willing to pay $4.15 billion for its Ortho Clinical Diagnostics division, which provides blood-testing equipment and chemicals. One would think that blood testing should be a booming ...
Tags: Get out of Blood Testing Tech, J&J
US-based medical device company Varian Medical Systems has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its updated ProBeam proton therapy system. Using the ProBeam system, clinicians can deliver the dose ...
Tags: Varian Medical, IMPT, ProBeam system
Illumina has entered into an agreement with Amgen to develop and commercialize a multigene, NGS-based test as a companion diagnostic for Vectibix (panitumumab), a fully human anti-EGFR monoclonal antibody therapeutic for the treatment of ...
Tags: Amgen, FDA, CE, Illumina Oncology
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes cancer a deadly ...
Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its updated ProBeam™ proton therapy system. Varian's ProBeam system gives clinicians options for delivering dose precisely in order to minimize dose to healthy ...
Tags: Health, Medicine, Varian Medical Systems
Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
In 2004, a form of cancer known as neuroblastoma claimed the life of Alexandra (Alex) Scott, a little girl who gained national attention for using her lemonade stand to raise money for cancer research. Now, the organization established in ...
Tags: neuroblastoma, Alex's Lemonade Stand Foundation, University of Maryland
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody ...